Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00191815 | Combination Chemotherapy for Metastatic Breast Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 2 | Nov 11, 2009 | clinicaltrials |
| NCT00617968 | GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer | completed | Phase 2 | 5 | SanofiINDUSTRY | 1 | Sep 2, 2009 | clinicaltrials |
| NCT00002679 |
| Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer |
| completed |
| Phase 2 |
| 89 |
| Yale UniversityOTHER |
| 1 |
| Aug 26, 2009 |
| clinicaltrials |
| NCT00080743 | Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer | completed | Phase 2 | 2 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00123929 | Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel or Doxorubicin in Locally Advanced Breast Cancer | completed | Phase 2 | 250 | Hospital San Carlos, MadridOTHER | 1 | Aug 6, 2009 | clinicaltrials |
| NCT00316199 | Efficacy Study of Gemcitabine-Paclitaxel to Treat Metastatic Breast Cancer | completed | Phase 2 | 60 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 17, 2009 | clinicaltrials |
| NCT00919399 | Exemestane (Aromasine) + Tamoxifen - Breast Neo-Adjuvant(TAMARO) | completed | Phase 2 | 15 | Institut Claudius RegaudOTHER | 1 | Jun 12, 2009 | clinicaltrials |
| NCT00287534 | Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women.(ARNO-95) | completed | Phase 2 | 1,059 | AstraZenecaINDUSTRY | 1 | Jun 9, 2009 | clinicaltrials |
| NCT00096668 | Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer | completed | Phase 2 | 47 | Achieve Life SciencesINDUSTRY | 1 | Jun 4, 2009 | clinicaltrials |
| NCT00306631 | A Study to Determine the Antitumor Activity and Evaluate the Safety of MKC-1 | completed | Phase 2 | 65 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jun 3, 2009 | clinicaltrials |
| NCT00106002 | Pemetrexed as the First Treatment in Advanced or Metastatic Breast Cancer | completed | Phase 2 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 1, 2009 | clinicaltrials |
| NCT00063570 | Pemetrexed Plus Gemcitabine in Metastatic Breast Cancer Patients After Receiving Taxane Therapy | completed | Phase 2 | 73 | Eli Lilly and CompanyINDUSTRY | 2 | May 29, 2009 | clinicaltrials |
| NCT00036023 | Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies | completed | Phase 2 | — | AmgenINDUSTRY | 0 | May 11, 2009 | clinicaltrials |
| NCT00087958 | Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment | completed | Phase 2 | 168 | SanofiINDUSTRY | 15 | May 1, 2009 | clinicaltrials |
| NCT00234403 | A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer | completed | Phase 2 | 60 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00247481 | ZD1839 (Iressa™) In Combination With Docetaxel As First-Line Treatment In Patients With Metastatic Breast Cancer | completed | Phase 2 | 77 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00255463 | Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study | completed | Phase 2 | 185 | AstraZenecaINDUSTRY | 7 | Apr 23, 2009 | clinicaltrials |
| NCT00637026 | Ph II Early BC Pre-Surgical Biologic Study | completed | Phase 2 | 65 | AstraZenecaINDUSTRY | 0 | Apr 23, 2009 | clinicaltrials |
| NCT00632723 | IRESSA™ (Gefitinib) in Breast Cancer Patients | completed | Phase 2 | 54 | AstraZenecaINDUSTRY | 0 | Apr 22, 2009 | clinicaltrials |
| NCT00043368 | PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909) | completed | Phase 2 | 31 | PfizerINDUSTRY | 2 | Mar 12, 2009 | clinicaltrials |
| NCT00043394 | CPG 7909 Plus Herceptin® In Patients With Metastatic Breast Cancer | completed | Phase 2 | 16 | PfizerINDUSTRY | 1 | Mar 12, 2009 | clinicaltrials |
| NCT00200824 | Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health | completed | Phase 2 | — | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Mar 12, 2009 | clinicaltrials |
| NCT00612443 | Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy | completed | Phase 2 / Phase 3 | 40 | University of Wisconsin, MilwaukeeOTHER | 1 | Jan 21, 2009 | clinicaltrials |
| NCT00364195 | Tesmilifene in Combination With Docetaxel in the Treatment of Metastatic Breast Cancer | completed | Phase 2 | 33 | YM BioSciencesINDUSTRY | 1 | Jan 9, 2009 | clinicaltrials |
| NCT00127465 | Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their Confidants | completed | Phase 1 / Phase 2 | 400 | University of PlymouthOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00583739 | Yoga to Reduce Cancer Fatigue | completed | Phase 2 | 66 | University of IowaOTHER | 1 | Dec 4, 2008 | clinicaltrials |
| NCT00078000 | A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies. | completed | Phase 2 | 64 | PfizerINDUSTRY | 1 | Nov 26, 2008 | clinicaltrials |
| NCT00378313 | A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer | completed | Phase 2 | 76 | NSABP Foundation IncNETWORK | 1 | Nov 26, 2008 | clinicaltrials |
| NCT00198250 | Venlafaxine for Hot Flashes After Breast Cancer | completed | Phase 2 | 75 | Indiana UniversityOTHER | 1 | Nov 14, 2008 | clinicaltrials |
| NCT00072852 | Irinotecan in Patients With Advanced Metastatic Breast Cancer Who Have Experienced Failure of an Anthracycline, a Taxane, and Capecitabine | completed | Phase 2 | 134 | PfizerINDUSTRY | 5 | Oct 16, 2008 | clinicaltrials |
| NCT00115414 | Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Aug 1, 2008 | clinicaltrials |
| NCT00428896 | A Feasibility Study With Iressa in Resistant Cytokeratin-Positive Tumor Cells Circulating in the Blood of Women With Breast Cancer | completed | Phase 2 | 24 | University Hospital of CreteOTHER | 1 | Jul 21, 2008 | clinicaltrials |
| NCT00217815 | Preliminary Study of Mycograb and Docetaxel in Advanced Breast Cancer | completed | Phase 1 / Phase 2 | 20 | NeuTec PharmaINDUSTRY | 2 | Jul 15, 2008 | clinicaltrials |
| NCT00093002 | Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer | completed | Phase 2 | 179 | AstraZenecaINDUSTRY | 6 | Jun 12, 2008 | clinicaltrials |
| NCT00212082 | Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer | completed | Phase 2 | 100 | National University Hospital, SingaporeOTHER | 1 | Jun 12, 2008 | clinicaltrials |
| NCT00386087 | Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy | completed | Phase 2 | 41 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 6, 2008 | clinicaltrials |
| NCT00201435 | Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC | completed | Phase 2 / Phase 3 | 224 | Norwegian Breast Cancer GroupOTHER | 1 | May 20, 2008 | clinicaltrials |
| NCT00286247 | Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer | completed | Phase 2 | 60 | Introgen TherapeuticsINDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00001193 | A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer | completed | Phase 2 | 200 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001239 | Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001250 | Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial | completed | Phase 2 | 130 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001805 | A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00026962 | Effects of Raloxifene on Hormone Levels | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00278070 | Metronomic Oral Vinorelbine in Patients With Metastatic Tumors | completed | Phase 2 | — | Hellenic Cooperative Oncology GroupOTHER | 1 | Feb 29, 2008 | clinicaltrials |
| NCT00046371 | Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients | completed | Phase 2 | — | Oncothyreon Canada Inc.INDUSTRY | 1 | Jan 23, 2008 | clinicaltrials |
| NCT00120692 | Treatment for Patients Suffering From Anemia Due to Chemotherapy | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00146601 | Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer | completed | Phase 2 | 35 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 21, 2007 | clinicaltrials |
Data updated 23 days agoSource updated Nov 11, 2009source: clinicaltrials